0.05
0.00%
Close of 9 Nov 2026, in CAD
Search any instrument
Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.
About KDA Group
Its shares trade on TSX Venture under the ticker KDA.V. It has been listed since 9 September 2009. In the fiscal year to 31 July 2025, it reported revenue of C$165,403 and a net loss of C$8.0m. At that date it held total assets of C$11.3m and shareholders' equity of C$10.9m.
KDA Group, Inc. engages in the provision of solutions and services to pharmaceutical market. The company is headquartered in Thetford Mines, Quebec. The company went IPO on 2009-09-09. The Company’s segments include Pharmacy Services, Pharmaceutical Solutions and Pharmaceutical Technology. Its Pharmacy Services segment offers training, consulting, and replacement services for professional resources in the field of healthcare. Its Pharmaceutical Solutions segment is engaged in the development and integration of technological platforms dedicated to all healthcare professionals. Its Pharmaceutical technology segment offers KRX, KRX DENTAL and ADRX platforms. The company also offers ZRx Digital Prescriber an electronic prescriber computer and mobile software designed and developed for use by healthcare providers who are authorized to prescribe medications and other treatments. Its subsidiaries include Alliance Pharma Operations Inc., Elitis Pharma Inc., Logistik Pharma Inc. and Groupe Technologique KDA Inc.
Figures and description from our data supplier, not checked against the company's own report.
Company facts
- Sector
- Health Care
- Industry
- Health Care Providers & Services
- Listed since
- 9 Sept 2009
- Website
- alliancepharma.ca ↗
Leadership
Pay as last reported
- Mr. Marc LemieuxChairman of the Board, President, Chief Executive Officer, since 2015C$338,935
- Mr. Michael KinleyChief Financial Officer, Director, since 2023C$61,542
- Ms. Isabelle BeginDirector, since 2015C$31,927
- Mr. Patrick FernetIndependent DirectorC$304,571
Environmental, social and governance
Scores out of 100, from our data supplier
- Overall
- 0
- Environment
- 0
- Social
- 0
- Governance
- 0
SWOT analysis
AI-generated by our data supplier. Not written or checked by our editors.
Strengths
- KDA Group Inc. provides Pharmacy Services for healthcare professionals in Canada.
- Pharmaceutical Solutions segment develops technological platforms for healthcare professionals.
- KRX, KRX DENTAL, and ADRX platforms are key products in Pharmaceutical Technology segment.
Weaknesses
- Thetford Mines, Quebec is a small city with limited resources for growth.
- Pharmacy Services segment lacks international expansion beyond Canada.
- KDA Group Inc. has no presence in the Financials or Real Estate sectors.
Opportunities
- Expanding Pharmacy Services into the United States market could increase revenue.
- The growing Health Care sector in Canada offers new opportunities for Pharmaceutical Solutions.
- ZRx Digital Prescriber software can be adopted by more healthcare providers in Canada.
Threats
- Competition from larger pharmaceutical companies in Canada threatens market share.
- Regulatory changes in the Health Care industry could impact operations.
- Economic downturns in Canada may reduce healthcare spending.
Sources and methodology
- Data on this tab
- Our data supplier
- Chart on the Overview
- TradingView
Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.